Quinnova Pharmaceuticals, Inc., a specialty dermatological reformulation pharmaceutical company focused on innovative dermal drug delivery platforms, has completed a $13.6M Series A round of financing. Participating in the round are Thomas, McNerney & Partners, H.I.G. Ventures and an investor syndicate led by Omnivest (Bermuda) Ltd.
Quinnova Pharmaceuticals: Series A $13.6M
December 8, 2006
Leave a Comment » | 
I - Series A, R - NORTH EAST, X - Dermatology | 
Permalink
Posted by arubenstein
